Industry News
Researchers Have Discovered A New Gene Target For Leukemia Therapy
Jul 06, 2012
These findings, slated for the July 26, 2012 print issue of Blood, the journal of the American Society of Hematology, could lead to cellular targets for a patient population that otherwise may not have desirable outcomes and could potentially stop the onset of leukemia before it begins... Read More
Combination Therapy For Breast Cancer Shows Promise
Jul 06, 2012
A study published in the July issue of Anticancer Research reveals that scientists from Boston University School of Medicine (BUSM) have found an effective combination therapy for breast cancer cells in vitro that can potentially be used for treating different forms of breast cancer, including cancers resistant to chemotherapy as well as other treatments... Read More
Combination Therapy For Breast Cancer Shows Promise
Jul 06, 2012
A study published in the July issue of Anticancer Research reveals that scientists from Boston University School of Medicine (BUSM) have found an effective combination therapy for breast cancer cells in vitro that can potentially be used for treating different forms of breast cancer, including cancers resistant to chemotherapy as well as other treatments... Read More
Shedding Light On Pregnancy Complications And Overturning Common Belief
Jul 06, 2012
A study led by Hospital for Special Surgery researchers has demonstrated that women who have a specific type of antibody that interferes with blood vessel function are at risk for adverse pregnancy outcomes and that other antibodies in the same family thought to cause pregnancy complications do not put women at risk... Read More
When To Administer Multiple Myeloma Treatment Depends On Cancer Cell Cycle
Jul 05, 2012
A new study conducted by researchers from Weill Cornell Medical College reveals that precise timing of cell's cycle targeting cancer therapies disable key survival genes and lead to cell death. The study, published online in the journal Blood, shows that researchers have come up with a unique strategy of using two anti-cancer drugs in a series, similar to a combination of boxing punches... Read More
When To Administer Multiple Myeloma Treatment Depends On Cancer Cell Cycle
Jul 05, 2012
A new study conducted by researchers from Weill Cornell Medical College reveals that precise timing of cell's cycle targeting cancer therapies disable key survival genes and lead to cell death. The study, published online in the journal Blood, shows that researchers have come up with a unique strategy of using two anti-cancer drugs in a series, similar to a combination of boxing punches... Read More
Oral Cancer Virus Associated With Gum Disease
Jul 05, 2012
After the discovery that severe gum disease can be associated with a higher risk of head and neck cancer cases caused by the Human Pailloma Virus (HPV), The British Dental Health Foundation aims to educate the public on good oral health... Read More
Oral Cancer Virus Associated With Gum Disease
Jul 05, 2012
After the discovery that severe gum disease can be associated with a higher risk of head and neck cancer cases caused by the Human Pailloma Virus (HPV), The British Dental Health Foundation aims to educate the public on good oral health... Read More
Caffeine Intake Tied To Lower Risk Of Common Skin Cancer
Jul 05, 2012
A new US study of over 110,000 people found that the more caffeine there was in their diets, the lower their risk of developing basal cell carcinoma, the most common type of skin cancer. The researchers write about their findings in the 1 July issue of the journal Cancer Research... Read More
Caffeine Intake Tied To Lower Risk Of Common Skin Cancer
Jul 05, 2012
A new US study of over 110,000 people found that the more caffeine there was in their diets, the lower their risk of developing basal cell carcinoma, the most common type of skin cancer. The researchers write about their findings in the 1 July issue of the journal Cancer Research... Read More
Previous Page Next Page